These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

891 related items for PubMed ID: 12419479

  • 21. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.
    Tchernof A, Lamarche B, Prud'Homme D, Nadeau A, Moorjani S, Labrie F, Lupien PJ, Després JP.
    Diabetes Care; 1996 Jun; 19(6):629-37. PubMed ID: 8725863
    [Abstract] [Full Text] [Related]

  • 22. [Physiology and pathophysiology of the metabolism of lipoproteins].
    Sandhofer F.
    Wien Med Wochenschr; 1994 Jun; 144(12-13):286-90. PubMed ID: 8650930
    [Abstract] [Full Text] [Related]

  • 23. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM, van Greevenbroek MM, Krauss RM, Brouwers MC, Vermeulen VM, Robertus-Teunissen MG, van der Kallen CJ, de Bruin TW.
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [Abstract] [Full Text] [Related]

  • 24. HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease.
    Kwiterovich PO.
    Clin Chem; 1988 Apr; 34(8B):B71-7. PubMed ID: 3042202
    [Abstract] [Full Text] [Related]

  • 25. Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins.
    Zambon A, Bertocco S, Vitturi N, Polentarutti V, Vianello D, Crepaldi G.
    Biochem Soc Trans; 2003 Oct; 31(Pt 5):1070-4. PubMed ID: 14505482
    [Abstract] [Full Text] [Related]

  • 26. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ, de Bruin TW, Demacker PN, Kastelein JJ, Stalenhoef AF.
    Am J Cardiol; 1995 Feb 15; 75(5):348-53. PubMed ID: 7856526
    [Abstract] [Full Text] [Related]

  • 27. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
    Xu YX, Redon V, Yu H, Querbes W, Pirruccello J, Liebow A, Deik A, Trindade K, Wang X, Musunuru K, Clish CB, Cowan C, Fizgerald K, Rader D, Kathiresan S.
    Atherosclerosis; 2018 Jan 15; 268():196-206. PubMed ID: 29183623
    [Abstract] [Full Text] [Related]

  • 28. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein.
    Packard CJ.
    Biochem Soc Trans; 2003 Oct 15; 31(Pt 5):1066-9. PubMed ID: 14505481
    [Abstract] [Full Text] [Related]

  • 29. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ.
    Atheroscler Suppl; 2011 Nov 15; 12(3):277-84. PubMed ID: 22152282
    [Abstract] [Full Text] [Related]

  • 30. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
    Murdoch SJ, Breckenridge WC.
    Biochim Biophys Acta; 1996 Oct 18; 1303(3):222-32. PubMed ID: 8908157
    [Abstract] [Full Text] [Related]

  • 31. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
    Lamarche B, Lemieux I, Després JP.
    Diabetes Metab; 1999 Sep 18; 25(3):199-211. PubMed ID: 10499189
    [Abstract] [Full Text] [Related]

  • 32. Changes in particle size of high density lipoproteins during incubation with very low density lipoproteins, cholesteryl ester transfer protein and lipoprotein lipase.
    Newnham HH, Barter PJ.
    Biochim Biophys Acta; 1992 May 08; 1125(3):297-304. PubMed ID: 1596518
    [Abstract] [Full Text] [Related]

  • 33. The role of non-LDL:non-HDL particles in atherosclerosis.
    Segrest JP.
    Curr Diab Rep; 2002 Jun 08; 2(3):282-8. PubMed ID: 12643186
    [Abstract] [Full Text] [Related]

  • 34. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes.
    Krentz AJ.
    Diabetes Obes Metab; 2003 Nov 08; 5 Suppl 1():S19-27. PubMed ID: 14984018
    [Abstract] [Full Text] [Related]

  • 35. Abnormalities in metabolism of low density lipoproteins associated with coronary heart disease.
    Grundy SM, Vega GL, Kesäniemi YA.
    Acta Med Scand Suppl; 1985 Nov 08; 701():23-37. PubMed ID: 3907293
    [Abstract] [Full Text] [Related]

  • 36. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance.
    Tan KC, Cooper MB, Ling KL, Griffin BA, Freeman DJ, Packard CJ, Shepherd J, Hales CN, Betteridge DJ.
    Atherosclerosis; 1995 Mar 08; 113(2):273-87. PubMed ID: 7605366
    [Abstract] [Full Text] [Related]

  • 37. Lipoproteins and atherosclerosis.
    Babiak J, Rudel LL.
    Baillieres Clin Endocrinol Metab; 1987 Aug 08; 1(3):515-50. PubMed ID: 3330421
    [Abstract] [Full Text] [Related]

  • 38. Regulation of plasma triglycerides in insulin resistance and diabetes.
    Ginsberg HN, Zhang YL, Hernandez-Ono A.
    Arch Med Res; 2005 Aug 08; 36(3):232-40. PubMed ID: 15925013
    [Abstract] [Full Text] [Related]

  • 39. Effects of dietary fat restriction on particle size of plasma lipoproteins in postmenopausal women.
    Kasim-Karakas SE, Lane E, Almario R, Mueller W, Walzem R.
    Metabolism; 1997 Apr 08; 46(4):431-6. PubMed ID: 9109849
    [Abstract] [Full Text] [Related]

  • 40. Metabolic syndrome and renal failure: similarities and differences.
    Kaysen GA.
    Panminerva Med; 2006 Sep 08; 48(3):151-64. PubMed ID: 17122751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.